| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $270.3M | +20.5% |
| Cost of Revenue | $114.8M | +26.1% |
| Gross Profit | $155.5M | +16.7% |
| R&D Expense | $3.0M | -1.7% |
| SG&A Expense | $121.4M | +14.3% |
| Operating Income | $22.9M | +28.2% |
| Pre-tax Income | $21.8M | +34.6% |
| Income Tax | $6.4M | +34.2% |
| Net Income | $14.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.5M | -23.0% |
| Accounts Receivable | $25.6M | +2.7% |
| Inventory | $5.0M | +16.8% |
| Current Assets | $48.5M | -8.3% |
| Total Assets | $199.2M | +12.5% |
| Current Liabilities | $41.1M | +10.0% |
| Long-term Debt | $11.3M | +214.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $51.9M | +32.8% |
| Capital Expenditures | $40.0M | +5.9% |
| Investing Cash Flow | -$50.2M | -63.4% |
| Financing Cash Flow | -$5.8M | -56.9% |
| Free Cash Flow | $11.9M | +805.2% |
| +32.6% |
| EPS (Basic) | $0.38 | +31.0% |
| EPS (Diluted) | $0.37 | +32.1% |
| Total Liabilities |
| $55.6M |
| +27.1% |
| Stockholders' Equity | $141.5M | +7.7% |